![](/img/cover-not-exists.png)
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer
Martinez-Useros, Javier, Rodriguez-Remirez, Maria, Borrero-Palacios, Aurea, Moreno, Irene, Cebrian, Arancha, Gomez del Pulgar, Teresa, del Puerto-Nevado, Laura, Vega-Bravo, Ricardo, Puime-Otin, AlbertVolume:
14
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/1471-2407-14-965
Date:
December, 2014
File:
PDF, 2.05 MB
english, 2014